BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/15/2023 10:42:35 AM | Browse: 323 | Download: 918
 |
Received |
|
2023-06-17 19:44 |
 |
Peer-Review Started |
|
2023-06-17 19:46 |
 |
First Decision by Editorial Office Director |
|
2023-07-04 08:49 |
 |
Return for Revision |
|
2023-07-04 08:49 |
 |
Revised |
|
2023-07-16 16:47 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2023-08-11 02:36 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2023-08-11 08:22 |
 |
Articles in Press |
|
2023-08-11 08:22 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2023-09-08 15:07 |
 |
Publish the Manuscript Online |
|
2023-09-15 10:42 |
| ISSN |
2220-315x (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Neurosciences |
| Manuscript Type |
Review |
| Article Title |
Neurologic orphan diseases: Emerging innovations and role for genetic treatments
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Ivelina P Kioutchoukova, Devon T Foster, Rajvi N Thakkar, Marco A Foreman, Brandon J Burgess, Rebecca M Toms, Eduardo E Molina Valero and Brandon Lucke-Wold |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Brandon Lucke-Wold, MD, PhD, Neurosurgeon, Department of Neurosurgery, University of Florida, 1505 SW Archer Rd, Gainesville, FL 32611, United States. brandon.lucke-wold@neurosurgery.ufl.edu |
| Key Words |
Neurologic orphan diseases; gene therapy; Clustered regularly interspaced palindromic repeats/Cas9; Antisense oligonucleotides; Adeno-associated virus; mTOR inhibitors |
| Core Tip |
Neurologic orphan diseases are rare conditions that impact a small percentage of the population. Through new advances in technology and research, the use of genetic treatment for these conditions is increasing. Recent advances in clustered regularly interspaced palindromic repeats/Cas9, adeno-associated viral vectors, antisense oligonucleotides, and mammalian target of rapamycin inhibitors have shown improvements in the care of patients and their quality of life. |
| Publish Date |
2023-09-15 10:42 |
| Citation |
Kioutchoukova IP, Foster DT, Thakkar RN, Foreman MA, Burgess BJ, Toms RM, Molina Valero EE, Lucke-Wold B. Neurologic orphan diseases: Emerging innovations and role for genetic treatments. World J Exp Med 2023; 13(4): 59-74 |
| URL |
https://www.wjgnet.com/2220-315x/full/v13/i4/59.htm |
| DOI |
https://dx.doi.org/10.5493/wjem.v13.i4.59 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.